The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
NCT ID: NCT06576154
Last Updated: 2024-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
200 participants
INTERVENTIONAL
2024-08-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Antibiotics in Groin Hernioplasty
NCT07111702
Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
NCT01273818
Prophylactic Antibiotic Use in Hernioplasty
NCT00636831
Antibiotic Prophylaxis in Mesh Repair of Inguinal Hernias
NCT01264003
Factors Related to Infection Prevention After Tension-free Inguinal Hernia Repair
NCT01802606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prophylaxis antibiotics Group
Patients with Antibiotic Prophylaxis post-open Repair of Primary Elective Groin Hernias in High-Risk Patients.
Cefazolin 1000 MG
* Medication: Cefazolin
* Dosage: 1 gram
* Administration Timing: A single dose will be administered preoperatively.
Non-antibiotics Group
Patients without Antibiotic Prophylaxis post-open Repair of Primary Elective Groin Hernias in High-Risk Patients.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cefazolin 1000 MG
* Medication: Cefazolin
* Dosage: 1 gram
* Administration Timing: A single dose will be administered preoperatively.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elderly patients aged over 60 years.
* Patients with Diabetes.
* Or obese patients with a BMI greater than 35.
* Or immunocompromised patients.
* Or American Society of Anesthesiologists (ASA) physical status classification 2 or more, with a history of more than 10 years.
Exclusion Criteria
* Therapeutic Indication for.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aleppo University Hospital Resident Team
UNKNOWN
University of Aleppo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmad Yamen Arnaout
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aleppo University Hospital
Aleppo, , Syria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP-GH-OE-2023-HR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.